NIH-funded research R01 grant

Understanding how MEOX2 affects lung development in premature infants

Official title: MEOX2: A Critical Regulator of Alveolar Fibroblast Function

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11136623 · Data updated 2026-11-12

This study is looking at how a specific gene called MEOX2 affects lung cells that help develop the lungs in premature babies, with the goal of finding new ways to treat lung problems like Bronchopulmonary Dysplasia (BPD).

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJune 1, 2025
Project endMarch 31, 2029
Funding year2025
Award (this year)$721,826
NIH project number1R01HL164418-01A1
Project IDNIH-11136623 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants diagnosed with Bronchopulmonary Dysplasia or related chronic lung conditions.

Less likely to help

Patients who are not premature or do not have chronic lung diseases may not benefit from this research.

What this research studies

This research investigates the role of the MEOX2 gene in the function of alveolar fibroblasts, which are crucial for lung development, particularly in premature infants. The study aims to uncover the molecular mechanisms that regulate the formation and maturation of alveoli, the tiny air sacs in the lungs. By analyzing changes in fibroblast function during lung development and disease, the researchers hope to identify potential therapeutic targets for conditions like Bronchopulmonary Dysplasia (BPD). The approach includes using animal models and advanced genetic techniques to observe the effects of manipulating MEOX2 expression.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve lung function and outcomes for premature infants suffering from chronic lung diseases.

How similar studies have gone: Previous research has shown promising results in understanding the role of fibroblasts in lung development, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Perl, Anne-Karina Theresia — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Perl, Anne-Karina Theresia

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.